Near East University Medical Faculty, Department of Radiology, Lefkosa/North Cyprus, Turkey.
Clin Imaging. 2013 Jul-Aug;37(4):692-6. doi: 10.1016/j.clinimag.2013.01.012. Epub 2013 Feb 27.
Any distinction and the usefulness of semiquantitative parameters derived from dynamic-contrast-enhanced (DCE) MRI obtained with extracellular gadolinium contrast agent in hemangiomas, hepatocellular carcinomas (HCC) and metastases of the liver was studied prospectively.
Seventy-four focal liver lesions (consisted of 34 hemangiomas, 23 HCC, and 17 metastases) of the 37 patients underwent DCE-MRI (six phases). Functional coloured maps and subsequently semiquantitative parameters were obtained using the FuncTool. Maximum and average (avg) values of mean time to enhancement (MTE), positive enhancement integral (PEI), time to peak (TP), maximum slope of increase (MSI), maximum slope of decrease (MSD) values were measured by placing the region of interest. The diagnosis of HCC and metastases were proven histopathologically and/or clinically.
The mean values of the paremeters were: In hemangiomas, avgMTE: 271.2 ± 4.7; avgPEI: 840.3 ± 77.3; avgTP: 146.6 ± 13.1; avgMSI: 999.1 ± 108.4; avgMSD: 254.1 ± 30.4. In HCC, avgMTE: 246 ± 3.6; avgPEI: 424.9 ± 31.6; avgTP: 132.8 ± 9.5; avgMSI: 484.1 ± 36.5; avgMSD: 109.1 ± 13.3. In metastases, avgMTE: 248.1 ± 8.2, avgPEI: 453.9 ± 39.6; avgTP: 142.8 ± 13.9; avgMSI: 472.6 ± 50.4 and avg MSD: 200.1 ± 38.2. Both maximum and avg values of MTE, PEI, MSI, and MSD were significantly higher in hemangiomas (P<.05). The most significant difference was found in avgPEI with 82.1% sensitivity and 67.6% specificity when 570 cutoff value was considered. The values however were not significantly different among HCC and metastases (P>.05).
Semiquantitative DCE-MRI parameters provide useful, complementary, and quantitative information. This technique increases diagnostic value of extracellular gadolinium contrast agent to characterize focal liver lesions and may be useful for follow-up after local-regional therapies.
本研究旨在前瞻性地研究从使用细胞外钆造影剂的动态对比增强(DCE)MRI 获得的半定量参数在血管瘤、肝细胞癌(HCC)和肝转移中的区别和有用性。
37 例患者的 74 个局灶性肝病变(包括 34 个血管瘤、23 个 HCC 和 17 个肝转移)接受了 DCE-MRI(六个阶段)检查。使用 FuncTool 获得功能彩色地图和随后的半定量参数。通过放置感兴趣区域来测量平均增强时间(MTE)、阳性增强积分(PEI)、达峰时间(TP)、最大斜率增加(MSI)、最大斜率降低(MSD)的最大和平均(avg)值。HCC 和转移瘤的诊断通过组织病理学和/或临床证实。
参数的平均值为:血管瘤中,avgMTE:271.2±4.7;avgPEI:840.3±77.3;avgTP:146.6±13.1;avgMSI:999.1±108.4;avgMSD:254.1±30.4。在 HCC 中,avgMTE:246±3.6;avgPEI:424.9±31.6;avgTP:132.8±9.5;avgMSI:484.1±36.5;avgMSD:109.1±13.3。在转移瘤中,avgMTE:248.1±8.2,avgPEI:453.9±39.6;avgTP:142.8±13.9;avgMSI:472.6±50.4,avgMSD:200.1±38.2。MTE、PEI、MSI 和 MSD 的最大和平均值在血管瘤中均显著升高(P<.05)。当考虑 570 个截断值时,平均 PEI 的敏感性为 82.1%,特异性为 67.6%,差异具有统计学意义。然而,HCC 和转移瘤之间的这些值无显著差异(P>.05)。
半定量 DCE-MRI 参数提供了有用的、互补的定量信息。该技术提高了细胞外钆造影剂在描述局灶性肝病变方面的诊断价值,并且可能对局部区域治疗后的随访有用。